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Abstract
Background: Mosquito-borne viral diseases cause significant burden in much of the developing world. Although host-virus
interactions have been studied extensively in the vertebrate host, little is known about mosquito responses to viral
infection. In contrast to mosquitoes of the Aedes and Culex genera, Anopheles gambiae, the principal vector of human
malaria, naturally transmits very few arboviruses, the most important of which is O’nyong-nyong virus (ONNV). Here we
have investigated the A. gambiae immune response to systemic ONNV infection using forward and reverse genetic
approaches.
Methodology/Principal Findings: We have used DNA microarrays to profile the transcriptional response of A. gambiae
inoculated with ONNV and investigate the antiviral function of candidate genes through RNAi gene silencing assays. Our
results demonstrate that A. gambiae responses to systemic viral infection involve genes covering all aspects of innate
immunity including pathogen recognition, modulation of immune signalling, complement-mediated lysis/opsonisation and
other immune effector mechanisms. Patterns of transcriptional regulation and co-infections of A. gambiae with ONNV and
the rodent malaria parasite Plasmodium berghei suggest that hemolymph immune responses to viral infection are diverted
away from melanisation. We show that four viral responsive genes encoding two putative recognition receptors, a galectin
and an MD2-like receptor, and two effector lysozymes, function in limiting viral load.
Conclusions/Significance: This study is the first step in elucidating the antiviral mechanisms of A. gambiae mosquitoes, and
has revealed interesting differences between A. gambiae and other invertebrates. Our data suggest that mechanisms
employed by A. gambiae are distinct from described invertebrate antiviral immunity to date, and involve the complement-
like branch of the humoral immune response, supressing the melanisation response that is prominent in anti-parasitic
immunity. The antiviral immune response in A. gambiae is thus composed of some key conserved mechanisms to target
viral infection such as RNAi but includes other diverse and possibly species-specific mechanisms.
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Introduction
Arthropod-borne viruses (arboviruses) are a significant health
burden across the world. They represent an emerging and resurgent
group of pathogens [1], many of which are transmitted by mosquitoes
including Dengue Fever (DEN), Yellow Fever (YF), West Nile Virus
(WNV) and Chikungunya (CHIKV). The development of control
strategies to combat the spread of these viruses requires a detailed
knowledge of host-pathogen interactions in both the vertebrate host
and invertebrate vector. Targeting human pathogens, for example
malaria parasites, within their insect vectors has been the focus of
intense research towards identification of novel targets for transmis-
sion blocking interventions. Understanding the molecular mecha-
nisms of immunity to pathogens within insect vectors could reveal
potential candidates for such interventions.
Extensive research has been carried out into insect immune
responses to bacterial, fungal and parasitic infections; however, it is
only recently that invertebrate antiviral immunity has received
analogous attention. Initial studies have used Drosophila melanogaster
as a model system, as the power of genetics and the extensive
knowledgebase in Drosophila have been invaluable in establishing
the foundations for insect antiviral immunity research. However,
the biology of arboviruses is tightly linked to the physiology of
haematophagous arthropods, and as such research in model
organisms may not be fully relevant to the transmission of viruses
and associated vector defence. A forward research approach is
required to effectively study the vector responses to arboviruses,
utilizing findings in Drosophila as guidance.
Mosquitoes launch robust immune responses against a variety of
pathogens: recognition of pathogen associated molecular patterns
(PAMPS) leads to activation of immune signalling pathways
associated with production of potent anti-microbial peptides
(AMPs) or cascades that lead to pathogen lysis, phagocytosis,
melanisation or cellular encapsulation by hemocytes, the white
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been implicated in mosquito antiviral immunity. The JAK/STAT
pathway, a known antiviral signalling pathway in mammals [3],
appears to have a conserved function in Aedes aegypti. JAK/STAT
related genes are differentially regulated in response to DENV
infection [4], and Ae. aegypti can be made more or less susceptible
to DENV through silencing of DOME (receptor of the JAK/STAT
pathway) and PIAS (negative regulator of the JAK/STAT
pathway) respectively [5]. In addition, 18 genes downstream of
the Ae. aegypti JAK/STAT pathway are regulated by DENV
infection, two of which have been shown to be DENV antagonists
[5]. The RNAi pathway has been demonstrated to limit viral
infection in several mosquito vector-virus combinations. AgAGO2
(a member of the RISC complex) is an antagonist of ONNV in A.
gambiae [6]; AeAGO2, AeDCR2 and AeTSN (all members of the
RNAi pathway) are Sindbis virus (SINV) antagonists in Ae. aegypti
[7]; AeDCR2 had also been shown to be a DENV antagonist [8].
The presence of viRNA (siRNA that is specific to viral genomes)
has been demonstrated in Ae. aegypti infected with SINV and
DENV [9,10], and recombinant viruses encoding suppressors of
RNAi have been shown to increase mortality, increase viral titres
and lower the build-up of viRNAs in infected mosquitoes [9,10].
Finally, Toll pathway related genes are differentially regulated in
response to both SINV and DENV infection in Ae. aegypti [4,11].
Activation and inhibition of the Toll pathway has been
demonstrated to respectively decrease and increase susceptibility
to different DENV strains in different Ae. aegypti strains showing the
importance of the Toll pathway in mosquito antiviral immunity
[4,12].
Whereas the Aedes and Culex mosquitoes transmit numerous
viruses, Anopheles mosquitoes (the principal vectors of malaria) are
known to be the primary vectors of only O’nyong-nyong virus
(ONNV). ONNV is a positive (sense) strand single stranded RNA
(+ssRNA) virus of the Alphavirus family, with reported epidemics
in West Africa in the 1960s and 1990s [13–18]. Viral replication of
ONNV in A. gambiae is shown to be slow and restricted in tissue
tropism compared to most vector-virus combinations [19].
Permissiveness to infection has been shown, in part, to be
regulated by RNAi, and inhibition of RNAi results in high
susceptibility to viral infection [6]. Here we have profiled the
global transcriptional responses of A. gambiae to ONNV infection of
the hemolymph to identify viral responsive genes, and then used
RNAi silencing to test a selection of identified genes for antiviral
function. Our results confirm that in A. gambiae the RNAi pathway
is a key antiviral mechanism, however, the JAK/STAT and the
Toll pathway do not have a significant role in regulating systemic
ONNV infection. We further identify four viral responsive genes
with novel functions in mosquito antiviral immunity. Patterns of
immune gene expression coupled with co-infections of A. gambiae
with the rodent malaria parasite P. berghei suggest that viral
infection inhibits parasite melanisation. Overall, we demonstrate
that A. gambiae uses a combination of conserved antiviral pathways,
including RNAi, and novel uncharacterised mechanisms to target
ONNV infections.
Materials and Methods
ONNV production and propagation
59ONNVic-eGFP plasmid was kindly provided by Dr Brian
Foy, Colorado State University. 59ONNCiv-eGFP infectious
clones were generated as described in [19] with some modifica-
tions. RNA generated in vitro from the infectious clone template
was purified using the RNeasy mini kit (Qiagen). RNA
concentration and purity was ascertained using a Nanodrop
(Labtech International). 2 mg of RNA were transfected into a
confluent culture of VERO cells in a T75 flask using the
Transmessenger transfection reagent (Qiagen). Cells were ob-
served for cytopathic effects and GFP expression at 24 hours post
transfection. At 72 hours post infection cells were scraped and
filtered through a 0.22 mm filter, aliquoted and stored at 280uC.
250 ml of first passage 59ONNVic-eGFP was used to infect a large
culture of confluent VERO cells. At 72 hours post infection cells
were scraped, filtered through a 0.22 mm filter, aliquoted and
stored at 280uC. Second passage virus was used in all
experiments.
Maintainence of G3 A. gambiae mosquitoes
Adult mosquitoes were maintained as described in detail by
Sinden and co-workers [20]. In brief, mosquitoes were reared and
maintained at 28uC, 65–70% relative humidity with a 12 hour
light/dark cycle. Adult mosquitoes were fed on sterile filtered and
autoclaved 10% fructose solution and used for experimental
purposes when 1 or 2 days old.
Infection of adult G3 mosquitoes
Newly emerged female mosquitoes were inoculated with the
required dilution of second passage 59ONNVic-eGFP in MEM
(Invitrogen), using a pulled capillary glass needle and a Nanoject
(Drummond Scientific). Inoculated mosquitoes were kept in
cohorts of 30–50 and maintained as described by [20]. Inoculated
mosquitoes were double-contained to prevent escape.
Qrt-PCR to assay viral titre in adult mosquitoes
Pools of ,30 whole mosquitoes were homogenised in 200 mlo f
Drosophila Schneiders medium (Gibco). Homogenates were
centrifuged at 3000 g for 30 minutes at 4uC to pellet debris.
Supernatant was transferred to a new 1.5 ml eppendorf tube and
centrifuged at 5000 rpm for a further 30 minutes at 4uC. The
supernatant was filtered through a 0.2 um filter, and 140 ml of the
filtrate was used for viral RNA extraction using the Qiagen viral
Author Summary
Mosquito-borne viral diseases are found across the globe
and are responsible for numerous severe human infec-
tions. In order to develop novel methods for prevention
and treatment of these diseases, detailed understanding of
the biology of viral infection and transmission is required.
Little is known about invertebrate responses to infection in
mosquito hosts. In this study we used a model system of
Anopheles gambiae mosquitoes and O’nyong-nyong virus
to study mosquito immune responses to infection. We
examined the global transcriptional responses of A.
gambiae to viral infection of the mosquito blood
equivalent (the hemolymph) identifying a number of
genes with immune functions that are switched on or off
in response to infection, including complement-like
proteins that circulate in the mosquito hemolymph. The
switching on of these genes combined with co-infection
experiments with malaria parasites suggests that viral
infection inhibits the melanisation pathway. Through
silencing the function of a selection of viral responsive
genes, we identified four genes that have roles in A.
gambiae anti-viral immunity; two putative recognition
receptors (a galectin and an MD2-like receptor); two
effector lysozymes. These molecules have previously non-
described roles in antiviral immunity, and suggest
uncharacterised mechanisms for targeting viral infection
in A. gambiae mosquitoes.
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10 ml of vRNA was used to generate cDNA using the Superscript
II kit (Invitrogen). To ascertain the abundance of viral RNA, or
viral genome copy number, an absolute quantification method was
used. cDNA was generated from vRNA extracted from a sample
with a known viral titre, calculated using standard plaque assay. A
standard curve the sample was generated using neat, 1:5, 1:10.
1:50, 1:100 and 1:500 dilutions of cDNA. Qrt-PCR was carried
out using SybrGreen reagents (Applied Biosystems) and primers
against the nsP3 ONNV gene (Table S3). The standard curve was
used to calculate the viral genome copy number of an unknown
sample by mapping the CT value to that of the standard curve,
giving the viral genome copy number.
Qrt-PCR to assay gene KD efficiency
Total RNA was extracted from pools of ,10 mosquitoes in
TRIzol (Invitrogen) 4 days after dsRNA treatment. cDNA was
generated from total RNA using the Superscript II kit (Invitrogen).
Primers were designed against GOIs such that there was no
overlap with dsRNA probes (Table S3) including the S7 gene that
is constitutively expressed in the mosquito. Qrt-PCR was carried
out using SybrGreen reagents (Applied Biosystems). cDNA input
was normalised using the abundance of S7 in each sample. Once
normalised, gene KD efficiency was calculated as a relative %
decrease in transcript abundance compared to a control KD
sample.
Plaque assay
Standard plaque assays were carried out as described in [21]. In
brief, individual mosquitoes were homogenised in 270 mlo f
Drosophila Schneiders medium (Gibco) and filtered through
0.22 mm filters. 10-fold serial dilutions of each sample were added
in duplicate to confluent monolayers of VERO cells in 24 well
plates and immobilised using an agar nutrient solution. Cells were
stained after 4 days incubation at 37uC using 200 ml of 5 mg/ml
Thiozolyl Blue Tetrazolium Bromide (MTT) (Sigma) in PBS.
Plaques of dead cells were counted and used to calculate the
plaque forming units (PFU)/mosquito.
Microarray hybridisation and analysis
Total RNA extracted from whole homogenates of A. gambiae
mosquitoes was amplified and labelled using the Low RNA Input
Amplification kit (Agilent, UK). In brief: 2 mg of total RNA was
used in a random primed reverse transcription reaction to
generate cDNA. After amplification by conversion to cDNA,
cDNA was transcribed to copy messenger RNA (cmRNA)
incorporating either Cy-3UTP (for the reference sample) or Cy-
5UTP (for the test sample) fluorescent nucleotide analogs. cmRNA
quality and labelling efficiency was assessed by spectrophotometry
using a Nanodrop (Labtech International). If cmRNA yield was
sufficient and Cy-3UTP or Cy-5UTP labelling was successful,
825 ng of RNA was hybridised to the Agilent 4X44K array in 26
GEx-hybridisation buffer HI-RPM at 60uC for 17 hours.
Hybridised slides were washed with GE wash buffer 1 at RT for
one minute and GE wash buffer 2 at 37uC for one minute, to
remove excess labelled cmRNA prior to scanning.
Microarrays were scanned using a GenePix semiconfocal
microarray scanner (AXON Instruments, Foster City, CA) Gene
Pix Pro 6.1 was used to record feature signal intensity, to eliminate
local backgrounds, for grid alignment and manual inspection of
feature quality. Average feature diameter was calculated and
features lying outside three standard deviations of the mean were
excluded from analysis. The ratio of feature intensity verses local
and global backgrounds were calculated and features not
exceeding background intensities were excluded from analysis.
Features were normalised using Genespring 6.1 (Axon instru-
ments) by locally weighted linear regression methods (Lowess).
Feature intensities of the three biological replicates were averaged.
T-test p-values were calculated, and normalised data was filtered
to exclude data with p-values greater than 0.05. Data was further
filtered to include only genes showing 2-fold and greater
regulation. Candidate genes were selected based on several
criteria, including gene ontology, and known roles of orthologous
genes. Microarray data has been submitted to the open access
Vectorbase database (www.vectorbase.org).
Design and production of dsRNA probes
Primers were designed (Table S3) for 200–600 bp sections of
genes of interest, with a T7 promotor sequence (GAATTAA-
TACGACTCACTATAGGGAGA) added to their 59 ends.
Polymerase chain reaction (PCR) was carried out using cDNA
derived from A. gambiae mosquitoes and PCR products were
sequenced to confirm correct amplification for each probe. PCR
amplicons were used to synthesise dsRNA using the T7 MEGA-
script kit (Ambion). Concentration of dsRNA was adjusted to
3 mg/ml and stored at 280uC until use.
Co-infections with P.berghei
P. berghei ANKA clone 259c12 was maintained in Theiler’s
original mice (Harlan, UK) as described in [20]. All animal work
was carried out by Dr Tibebu Habetewold and Kasia Sala. Mice
were infected by intraperitoneal (IP) injection of 100–200 mlo fP.
berghei infected blood. For mosquito infections, three days after
passage with infected blood mice were terminally anaesthetised
with an intramuscular (IM) injection of 0.05 ml/10 g body weight
of Rompun (2% stock solution, Bayer), Ketastet (100 mg/ml
ketamine, Fort Dodge Animal Health Ltd) and PBS in a 1:2:3
ratio.
Newly emerged adult G3 mosquitoes were intrathoracically
inoculated with ,1640 PFU 59ONNVic-eGFP. Inoculated
mosquitoes were maintained at 27uC for 48 h. Mosquitoes
were starved of sugar for 4–5 hours prior to blood feeding.
Mosquitoes were fed on a terminally anaesthetised P. berghei
infected mouse, maintained at 19uC for 72 h post blood feeding
to allow successful parasite development and were subsequent
maintained at 27uC to allow for optimal viral replication. Unfed
mosquitoes were removed between 24 and 48 h post blood
feeding, when the blood bolus is clearly visible through the
abdomen of the mosquito. Seven days post blood feeding,
mosquito midguts were dissected and fixed in 4% PFA. Fixed
midguts were mounted in Vectorshield (Vectorlabs) on glass
slides with sealed coverslips. Live oocysts expressing GFP were
counted using fluorescence, and melanised ookinetes were
counted using light microscopy.
Statistics
For plaque assay experiments and P. berghei oocysts/ookinete
quantification, results were subject to the Man Whitney U-test for
statistical significance. Significance was accepted where
P,0.001***, P,0.01**, P,0.05*. For analysis of changes in P.
berghei melanisation prevalence, results were subject to the Chi
Squared test for statistical significance, where P,0.001***.
Statistical significance in microarray experiments was calculated
using the T-test comparing normalised (Lowess) expression data.
Differential regulation was considered were fold change in
expression was greater than 2 and P,0.05 over three biological
replicates.
Mosquito Immunity to ONNV
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procedures
This study was carried out in strict accordance with the United
Kingdom Animals (Scientific Procedures) Act 1986. The protocols
for maintenance of mosquitoes by blood feeding and for infection
of mosquitoes with P. berghei by blood feeding on parasite-infected
mice were approved and carried out under the UK Home Office
License PLL70/6347 awarded in January 2008 and PPL70/7185
awarded in November 2010. The procedures are of mild severity
and the numbers of animals used are minimized by incorporation
of the most economical protocols. Opportunities for reduction,
refinement and replacement of animal experiments are constantly
monitored and new protocols are implemented following approval
by the Imperial College Ethical Review Committee. The
experimental procedures for the ONNV work were approved by
the HSE and the Imperial College GM Safety Committee.
Results
A. gambiae infections with ONNV
Using an infectious clone of ONNV encoding enhanced GFP
(59ONNVic-eGFP) under the control of a duplicated viral
subgenomic promoter (provided by B. D. Foy, AIDL, Colorado
state University [19]), we characterized infection of ONNV in
adult G3 A. gambiae mosquitoes. Adult mosquitoes were intratho-
racically inoculated with ,1640 PFU/mosquito. Viral RNA
(vRNA) was extracted from 10 pooled mosquitoes every day over
9 days and quantitative real-time PCR (qrt-PCR) was used to
calculate the viral genome copy number/mosquito (Figure 1A).
Viral titre increased slowly until 5 days post infection (DPI), when
infection rapidly increased, peaking at 7–8DPI, and then
subsequently decreased to low levels at 9DPI. Plaque assays using
individual mosquitoes at 7DPI showed that the prevalence of
infection was ,90% (data not shown). GFP expression was also
monitored at 1, 4 and 9 DPI by fluorescence microscopy of live,
cold anaesthetized mosquitoes (Figure 1B). GFP expression, most
commonly visible through the eyes (Figure 1C) and occasionally
through the thorax, was visible in only ,20% of mosquitoes at
4DPI and ,25% of mosquitoes at 9DPI. The discrepancy in
infection prevalence between plaque assays and GFP observations
is attributed to the mosquito cuticle that provides a barrier to GFP
detection and together with strong autofluorescence leads to
underestimation of the infection prevalence in whole mosquitoes.
In dissected mosquitoes at 7DPI, patterns of infection and tissue
tropism were in agreement with those previously published using
the same strain of A. gambiae mosquitoes and the same infectious
clone of ONNV [19]. Additionally GFP expression was commonly
seen in the midgut musculature of infected mosquitoes (Figure 1D)
similar to what has been previously observed in other vector-
alphavirus combinations [22,23].
Genome-wide transcriptional responses
In order to investigate the responses of A. gambiae to systemic
viral infection, we utilised a genome-wide microarray platform to
profile gene expression during a time-course of ONNV infection of
the hemocoel. Three time points were selected for analysis: 1DPI
(representing initial introduction of virus into the hemocoel), 4DPI
(where virus has replicated, is being released from infected cells
and is infecting new tissues) and 9DPI (where infection levels have
significantly dropped). Transcriptional profiling of whole mosquito
homogenates from infected versus mock-infected mosquitoes
revealed a large number of viral responsive genes. Initial exposure
to virus (1DPI) triggered the differential regulation of 66 genes (53
upregulated and 13 downregulated), increasing to 211 genes (119
upregulated and 92 downregulated) at 4DPI and dropping to 23
genes (20 upregulated and 3 downregulated) at 9DPI (Figure 2). A
full list of regulated genes is presented in Table S1. Genes were
grouped into functional categories based on gene ontology (GO)
terms, orthologous gene function and literature reviews. These
categories span a wide range of cellular and physiological processes
including metabolism, RNA degradation, signalling, and cell
division; however, the most striking category pertains to genes with
putative immune functions, particularly at 1DPI (30% of regulated
genes at 1DPI, 18% at 4DPI and 26% at 9DPI).
Overall, 45 genes with putative immune functions were
differentially regulated following ONNV infection. Grouping
these genes based on gene ontology and putative function (Table
S2) revealed genes with roles in all aspects of immunity, including
pathogen recognition, complement-like proteins, immune signal-
ling pathway components, humoral cascade regulators and
effector genes. The majority of genes (39/45) were upregulated,
consistent with the hypothesis that viral infection triggers immune
signalling in A. gambiae.
A surprisingly small number of genes from immune signalling
pathways known to respond to viral infection in other inverte-
brates were differentially regulated; comparison of viral responsive
genes with those downstream of the Toll and IMD pathway in A.
gambiae [24] and the JAK/STAT pathway in A. gambiae
(unpublished data) demonstrated very little overlap in gene
expression indicating that these pathways are not activated by
ONNV infection. In fact at 4DPI genes involved in the RNAi,
JAK/STAT and IMD pathways were downregulated suggesting
inhibition of these signalling pathways. Downregulated genes
encode the Tudor-SN (TSN), a component of the RNAi RISC
complex, the janus kinase HOP of the JAK/STAT pathway, and
IKKb, a positive regulator of the IMD pathway. In contrast to
decreased IKKb transcripts, DPT and CEC3 (AMPs thought to be
downstream of the IMD pathway) were upregulated at 1DPI and
4DPI.
Genes encoding putative recognition receptors were upregu-
lated at 1DPI and 4DPI; two MD2-like receptors (ML1/9), three
galectins (GALE6-8), one fibrinogen-like protein (FREP50) and
GNBPB1 all increased in transcript abundance. Additionally a
large number of genes encoding proteins implicated in humoral
immunity were upregulated, consisting of LRIMs and comple-
ment-like Thioester-containing proteins (TEPs). Different LRIMs
and TEPs were regulated during the different phases of infection;
LRIM1/4 and TEP5 at 1DPI; LRIM7 and TEP4/9/10/12 at
1DPI and 4DPI; LRIM10 and TEP14 at 4DPI and LRRD7 at
4DPI and 9DPI.
A number of clip-domain serine proteases and their inactive
homologs (CLIPs) and C-type lectins (CTLs) were upregulated
including two known inhibitors of melanisation (CTLMA2 and
CLIPA2). The roles of the other regulated CLIPs and CTLs are not
known, although they probably function in the modulation of
signalling that regulates humoral responses. Genes encoding
additional putative immune effectors were upregulated, the
majority of which at 4DPI, including two hydrogen peroxidases,
a glutathione peroxidase and three lysozymes. Additionally
apoptosis related genes also responded to viral infection.
Downregulation of the inhibitor of apoptosis-1 (IAP1) and
upregulation of Caspase-6 (CASPS6) at 4DPI suggests that
apoptosis may be triggered.
Gene silencing and ONNV infection phenotypic analysis
Transcriptional profiling highlighted immune genes that respond
to infection, however, whether these genes have genuine antiviral
functions could not be inferred from expression profiling alone. To
Mosquito Immunity to ONNV
www.plosntds.org 4 March 2012 | Volume 6 | Issue 3 | e1565identify genes that have roles in A. gambiae antiviral immunity we
developed an RNAi and qrt-PCR based assay to measure the effects
of gene knockdown (KD) on viral titres. Mosquitoes were co-
inoculated with dsRNA corresponding to a gene of interest and
,3000 PFU of 59ONNVic-eGFP. The viral RNA genome copy
number per mosquito was calculated 7DPI using qrt-PCR. 19 genes
were selected from the viral responsive immune genes identified in
ourtranscriptionalanalysisand from the classicalimmune signalling
pathways. DsRNA corresponding to AgAGO2 and the ONNV nsP3
gene were included as positive and negative controls respectively,
while dsRNA corresponding to the Escherichia coli LacZ gene was
used as a reference to calculate percentage changes in viral infection
loads. As expected KDof AgAGO2 resultedinincreased59ONNVic-
eGFP titres and nsP3 silencing resulted in decreased 59ONNVic-
Figure 1. A. gambiae G3 mosquitoes intrathoracically inoculated with 59ONNVic-eGFP. Mosquitoes were inoculated with ,1650 PFU of
59ONNVic-eGFP. (A) 10 inoculated mosquitoes were collected daily and qrt-PCR was used to ascertain viral genome copy number/mosquito. (B)
Percent of inoculated mosquitoes showing GFP expression at 1, 4 and 9 DPI. (C) Brightfield (BF) and fluorescent (GFP) images of GFP expression in the
head tissues through the ommatidia (O) of inoculated mosquitoes at 9 DPI and (D) Brightfield (BF) and fluorescent (GFP) images of GFP expression in
nerves and/or muscle bands in the anterior- (A) and mid-gut (M) of inoculated mosquitoes. Error bars represent standard deviation of 3 biological
replicates.
doi:10.1371/journal.pntd.0001565.g001
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(Figure 3). Interestingly, silencing of genes from the JAK/STAT
and the Toll pathways (HOP, STAT1-2, PIAS, REL1, CACT), which
are known to be involved in antiviral immunity in Ae. aegypti and D.
melanogaster, as well as of the IMD pathway (REL2) did not have an
effect on 59ONNVic-eGFP titres or yielded data that were highly
variable and therefore inconclusive. However, 5 of the 10 tested
viral responsive immune genes identified in our gene profiling
experiments appeared to be viral antagonists and were selected for
further investigation: the putative recognition receptors ML1 and
GALE8, and the antimicrobial peptides LYSC4, LYSC6 and CEC3.
In order to confirm that the 5 genes identified in our qrt-PCR
screen have a statistically significant impact on ONNV infection
we carried out plaque assays to measure the viral titres in
Figure 2. Transcriptional responses of A. gambiae G3 mosquitoes to 59ONNVic-eGFP infection. The transcriptional responses of A.
gambiae mosquitoes inoculated with <1640 PFU of 59ONNVic-eGFP infection were profiled using 4X44K Agilent RNA microarrays. Gene lists include
only features that pass strict criteria outlined in the materials and methods. Genes included the analysis are 2-fold or greater regulated at a minimum
of 1 of the 3 time points, with T-test P values of ,0.05. Genes were categorised based on gene ontology.
doi:10.1371/journal.pntd.0001565.g002
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genes consistently affected viral titres (Figure 4). ML1 KD resulted
in a 6.2 fold increase (P,0.0001), LYSC4 KD resulted in a 6 fold
increase (P,0.0001), LYSC6 KD resulted in a 5.4 fold increase
(P,0.001) and GALE8 KD resulted in a 2 fold increase
(P=0.0163) in median viral titres at 7DPI. The prevalence of
infection was similar for all genes tested (LacZ 89%, ML1 KD 95%,
GALE8 KD 95%, LYSC4 KD 89% and LYSC6 KD 93%). Qrt-
PCR was used to confirm the reduction of ML1 (91%), GALE8
(80%) and LYSC4 (82%) transcripts in mosquitoes after dsRNA
treatment and to confirm the transcriptional profile of these genes
after systemic infection (Figure S1); LYSC6 was not assayed.
A. gambiae co-infection with ONNV and P. berghei
Several recent studies have shown that the A. gambiae humoral
immune system exists in a delicate state of balance that can be
diverted to lysis or melanisation against malaria parasites [25,26].
To investigate whether the differential regulation of several
humoral immune factors observed during infection with ONNV,
including CLIPs, CTLs, LRIMs and TEPs, can influence this
balance we utilised A. gambiae co-infections with ONNV and the
rodent malaria, P. berghei.
Newly emerged female mosquitoes were injected with
,1640 PFU 59ONNVic-eGFP or mock infected and blood-fed
48 h later on a mouse infected with P. berghei. This experimental
design resulted in parasite ookinetes traversing the midgut wall
and entering the hemolymph approximately 4 days post ONNV
infection. Seven days post blood-feeding the mosquito midguts
were dissected and parasite oocysts and melanised ookinetes were
counted. Additionally, midguts were scored for ONNV infection
of the midgut musculature.
Figure 5A shows the oocyst and melanised ookinete distribution
in virally infected and mock infected mosquitoes. The results
revealed that priming with ONNV results in an approximately
40% reduction in the number of live oocysts in the virally infected
mosquitoes showing viral midgut infections, although this decrease
Figure 3. RNAi and qrt-PCR based screening of 19 genes for antiviral function in A. gambiae mosquitoes. Mosquitoes were injected with
dsRNA and ,3000 PFU of 59ONNVie-eGFP concurrently, 30 mosquitoes were collected at 7 DPI, and qrt-PCR was used to ascertain viral genome copy
number/mosquito. Values were normalised relative to the LacZ (non-specific) control and are given as a percentage relative to the LacZ titre. nsP3,a
viral gene was included in the screen. Genes are divided into functional categories based on which immune signalling pathway they belong to, or
their putative function. Genes with an asterisk* were selected for further characterisation.
doi:10.1371/journal.pntd.0001565.g003
Figure 4. Four antagonists of 59ONNVic-eGFP in A. gambiae
mosquitoes. Mosquitoes were injected with dsRNA and ,3000 PFU/
mosquito P1/P2V 59ONNVic-eGFP concurrently. Individual mosquitoes
were collected and subject the plaque assay at 7 DPI. Data was Log10
transformed. Bars represent the median from two independent
biological replicates. P values indicate significance from Man Whitney
U Testing of each gene KD compared to the LacZ control (P,0.05*,
P,0.01**, P,0.001***).
doi:10.1371/journal.pntd.0001565.g004
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However, a statistically significant decrease in the numbers of
melanised ookinetes was observed (P=0.001). The prevalence of
melanised ookinetes also significantly decreased from 35% in mock
infected to 18.5% in virally infected mosquitoes (Figure 5B)
(P,0.001 using the Chi squared test).
Discussion
Viruses as obligate intracellular pathogens represent a unique
challenge to the immune system and require sophisticated
mechanisms of recognition and targeting. Completing their
lifecycle within host cells and use of host cell membranes limits
the number of signatures that the immune system can recognise as
non-self. In this study we have attempted to elucidate the
components of the immune system employed by A. gambiae
mosquitoes to target ONNV through transcriptional profiling of
infected mosquitoes and gene silencing experiments.
Our observations of slow viral replication and restricted tissue
tropism within the A. gambiae mosquito host are consistent with
those observed for ONNV infections in the past [19]; it has been
suggested that the robust RNAi response observed in A. gambiae
mosquitoes [27] may contribute to the poor vectorial capacity of
these mosquitoes in comparison with other typical vector-virus
combinations [6]. Although not carried out in this study,
dissemination rates for ONNV infection in A. gambiae have also
been shown to be low compared to other vector-virus combina-
tions [19]. This indicates that A. gambiae is a poor vector of ONNV,
and may not be the natural vector of the disease outside of
epidemics [28].
Our transcriptional profiling of ONNV infected mosquitoes has
identified a large number of viral responsive genes. A significant
proportionofthesegeneshavenoknownfunction,indicatingthatA.
gambiae may utilise non-classical immune mechanisms to target viral
infection. Of the putative immune genes that were viral responsive,
a perhaps surprisingly small number were associated with the Toll
or JAK/STAT pathways. It has been shown in D. melanogaster and
Ae. aegypti that both the Toll and JAK/STAT pathways have
important roles in antiviral immunity [4,5,29]. In our study ONNV
infection fails to induce expression of components of these two
pathways; in fact HOP is downregulated at 4DPI. Additionally,
there is very little overlap between viral responsive genes and those
known to be downstream of the Toll pathway in A. gambiae [24] and
genes identified through microarray analysis of HOP KD A. gambiae
mosquitoes (unpublished data). Indeed through our gene silencing
experiments we have observed that activating or inhibiting both
pathways has little effect on ONNV titres. These data indicate that
not only does systemic ONNV infection fail to trigger Toll and
JAK/STAT signalling, but that genes downstream of these two
pathways do not target ONNV infection.
A possible contributing factor to the surprising difference observed
between Ae. aegypti and A. gambiae responses to viral infection may be
the route of infection used in the experimental designs. The JAK/
STAT and the Toll pathways have been shown to be important in
regulating flavivirus DENV midgut infection after an infectious blood
meal, which is the natural route of infection. In our study,
Figure 5. Co-infections of A. gambiae with P.berghei and 59ONNVic-eGFP. G3 mosquitoes were inoculated with ,1640 PFU 59ONNVic-eGFP
(+) or mock inoculated (2). 48 hours later mosquitoes were fed on a mouse infected with P. berghei.( A) 7 days post blood feeding midguts were
dissected, live oocysts (green)/melanised ookinetes (grey) were counted, and guts were scored positive or negative for 59ONNVic-eGFP expression in
midgut musculature or nerves. Parasite numbers were only included for the+virus category when 59ONNVic-eGFP expression was observed. Median
values for three biological replicates are represented by a black bar. Statistical significance was assessed using the Mann Whitney U test of three
biological replicates (**P,0.01). (B) Prevalence of parasite infection at 7 dpi in uninfected (mock) and infected (ONNV) midguts. Error bars represent
standard error of three biological replicates. Statistical significance was assessed using the Chi square test (***P,0.001).
doi:10.1371/journal.pntd.0001565.g005
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in order to overcome the restricted tissue tropism and very limited
dissemination rates observed following oral infection with ONNV,
thus achieving higher levels and prevalence of systemic infection.
Although a role of the JAK/STAT and the Toll pathway in midgut
defense against ONNV is possible, our results demonstrate that once
the virus enters the mosquito homocoel, immune responses other
than the JAK/STAT and the Toll pathways are involved in
regulating systemic antiviral immunity. Other studies investigating
immune responses of insects to alphavirus infection have also
s u g g e s t e do rd e m o n s t r a t e dt h a tt h eJ A K / S T A Ta n dT o l ls i g n a l l i n g
pathways do not target alphaviral infection. Sanders et al [11]
conducted microarray analysis of SINV infected Ae. aegypti;d e s p i t e
suggesting a role for the Toll pathway during early infection, they
found no differential regulation of JAK/STAT or Toll pathway
components. Fragkoudis et al (2008) [30] found that SFV in all
likelihood does not trigger classicalimmune signallingpathwaysinAe.
albopictus cells, and in fact infection inhibits activation of the JAK/
STAT, Toll and IMD pathways, probably through reducing host cell
gene expression. The difference observed between immune gene
regulation and function using Ae. aegypti/DENV and A. gambiae/
ONNV may also be a feature of flavivirus verses alphavirus infection
respectively.
In addition to Toll signalling, a second NF-kB signalling
pathway, the IMD pathway, regulates numerous genes that target
Plasmodium parasites and bacteria [24,31]. Our expression profiling
shows that IKKb, a positive regulator of the IMD pathway, is
downregulated at 4DPI, suggesting that the pathway may be
inhibited. In contrast, upregulation of LRIM1 and CEC3, which are
downstream targets of the A. gambiae IMD pathway [31], as well as
of a homolog of the AMP Diptericin that is downstream of the IMD
pathway in Drosophila [32], may suggest activation of the pathway.
Indeeda previousstudyhas demonstrated that the IMD,butnot the
Toll pathway, has an antiviral function during SIN infection of
Drosophila [33]. It is possible that the IMD, and not the Toll
pathway, responds to alphavirus infection, with the reverse being
true for flavivirus infection. Nevertheless, silencing REL2, the NF-
kB factor of the IMD pathway, has no significant effect on ONNV
titres, suggesting that the contribution of this pathway to ONNV
infection, whether inhibited or activated, is minor.
RNAi has been demonstrated in a number of invertebrates to
target and limit viral infection [6–10]. Our transcriptional
profiling does not show any induction of expression of RNAi
components, similar to observations of D. melanogaster infected with
DCV [29] and Ae. aegypti infected with DENV [4]. Presumably the
components of the RNAi pathway are constitutively expressed to
levels sufficient to target replicating viruses. We confirm that RNAi
is a key antiviral mechanism in A. gambiae mosquitoes through
silencing of the nsP3 viral gene and inhibition of RNAi by silencing
AgAGO2. Interestingly transcriptional profiling revealed that TSN,
a component of the RISC complex in the classical RNAi pathway,
is downregulated at 4DPI. It is possible that this downregulation is
mediated by ONNV, as inhibition of RNAi would be advanta-
geous for infection. ONNV and other alphaviruses are thought not
to encode a direct suppressor of RNAi [34] as seen in other insect
viruses such as the B2 protein of the FHV (Flock House Virus)
[35]; however, it is possible that viral gene products may interfere
with host gene expression. For example, 90% of Semliki Forest
Virus (SFV; a closely related alphavirus) nsP2 protein localises to
the nucleus of infected cells where its function is unknown but
could modulate expression of host genes [36].
In addition to the downregulation of TSN, two further genes
involved in the miRNA and piRNA pathways, DCR1 and AgAGO5,
and a group of DEAD-box helicases are downregulated at 4DPI.
There is evidence that the piRNA pathway has antiviral functions in
Drosophila,a sPiwi mutant flies are more susceptible to WNV than wild-
type flies [37]. The DEAD-box helicases, although having diverse
functions in RNA metabolism, are closely related to RIG-I and the
RIG-I-like receptors (RLRs) that have well defined roles in viral RNA
r e c o g n i t i o ni nm a m m a l i a ns y s t e m s[ 3 8 ] .I na d d i t i o n ,t h eh u m a n
DEAD-box helicase DDX3X also has antiviral roles, and multiple
viruses have been shown to interact with this protein and modulate its
function [39]. The downregulation of these genes suggests an intriguing
function in antiviral immunity. However, silencing of three helicases,
including DCR1, has no effect on ONNV titre.
In addition to the immune signalling pathways, A. gambiae
mosquitoes have a humoral branch of the immune system that
recognises and eliminates invading pathogens. A ternary complex of
two proteins of the LRIM family, LRIM1 and APL1C,a n dt h e
complement-like TEP1 has been shown to target invading Plasmodium
parasites for lysis or melanisation [25,40,41]. As our transcriptional
analysis showed that LRIM1 as well as several other members of the
LRIM and TEP families are upregulated following infection, we
investigated whether these humoral responses triggered by viral
infection can interfere with Plasmodium infections. ONNV and P.
berghei co-infections of A. gambiae were timed such that parasites
traverse the midgut and enter the hemolymph 4 days after ONNV
infection, thus encountering virus-induced humoral immune re-
sponses in the hemolymph. Our results reveal that parasite
melanisation is significantly inhibited in the presence of ONNV.
These results are consistent with our transcriptional analysis that
shows upregulation of two important negative regulators of
melanisation at 4DPI: CTLMA2 and CLIPA2 [42,43]. An observed
simultaneous decrease in the number of surviving parasites is not
dramatic suggesting that upregulation of LRIM1 alone is not sufficient
to cause significant parasite lysis, and that parallel upregulation of
APL1C and the complement effector protein TEP1 would be needed.
However, among additional TEPs upregulated by ONNV infection
are TEP4 and TEP9, which have been recently shown to also form
complexes with LRIM1 [44]. It remains to be investigated whether
the alternative LRIM1/TEP complexes promote antiviral responses
such as virus lysis or clearance of infected cells.
Four novel ONNV antagonists have been identified through our
RNAi screen; ML1, GALE8, LYSC4 and LYSC6. ML1 is one of two
MD-2 like receptors upregulated by ONNV infection and a known
P. falciparum antagonist [45]. The MD2 protein forms part of an
LPS sensing mechanism in mammals [46,47]. In addition to
responses to LPS, MD2-TLR4 signalling triggers the expression of
pro-inflammatory cytokines in response to ebola envelope protein
[48]. TLR4 signalling has also been linked to several other viral
infections including the vesicular stomatitus virus, respiratory
syncytial virus, mouse mammary tumor virus [48] and Kaposi
sarcoma herpesvirus [49]; however the role of MD2 in these
interactions is not clear. A TLR binding partner for the MLs has
yet to be identified in flies and mosquitoes. One hypothesis is that
the ML proteins may act as an extracellular surveillance system
that recognise viral PAMPs and lead to signalling via a Toll
receptor. At least 10 Toll receptors have been identified to date in
A. gambiae, but their role in immune responses is yet unclear [50].
Beta-galactoside binding galectins are found in many organisms
and display a complex repertoire: the multiple isoforms and their
observed plasticity in sugar binding suggests substantial diversity in
their glycan recognition properties [51]. There are 10 putative
galectins in A. gambiae [50], 3 of which are upregulated by ONNV
infection, GALE6-8. All three galectins are part of a mosquito
specific expansion of the Galectin family, including also GALE4
and GALE5. This expansion maybe due to the haematophagous
lifestyle of mosquitoes, and subsequent exposure to a disparate
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including viruses. Therefore, the upregulation of several galectins
in response to ONNV infection suggests that this group of
mosquito specific galectins have antiviral roles. Galectins are
known to function at several levels of antiviral defence, from initial
recognition and blocking of envelope and fusion glycoproteins to
the activation and amplification of the innate and adaptive
immune responses [51]. In mammals, Galectin 1 cross-links the N-
glycans displayed in the envelope proteins of Nipah and Hendra
viruses (paramyxoviruses that induce syncytia in infected cells),
directly blocking cell infection and cell-cell fusion [51]. In addition,
Galectin expression is regulated by Herpesvirus 1, Newcastle
disease [52], Epstein Barr Virus [53], Hepatitus C virus [54] and
Human papiloma virus (HPV) [55] while Galectin 3 secretion and
carbohydrate binding increase upon Herpesvirus 1 infection [56].
Three lysozymes are also induced by ONNV infection and two
of those, LYSC4 and LYSC6, appear to have antagonistic effects
against ONNV infections. Although lysozymes are classical
antibacterial proteins that function through perturbation of cell
membranes [57], many of them are also shown to have antiviral
immune functions including human urinary Lysozyme C, a
lysozyme from chicken egg whites, human milk lysozyme and
human neutrophil lysozyme, all of which have anti-Human
Immunodeficiency Virus (HIV) activity [58]. In addition, a
lysozyme from a marine organism is shown to inhibit Pseudo
Rabies Virus (PRV) growth in cell culture [59]. Although, the
mechanism of lysozyme antiviral activity is not clear, it is likely
that they also function through membrane perturbation.
In summary, this study is the first step in elucidating the
antiviral mechanisms of A. gambiae mosquitoes, and has revealed
interesting differences between A. gambiae and other invertebrates.
The finding that two pathways with known antiviral roles in other
invertebrate-virus systems do not significantly modulate systemic
ONNV infection indicates that A. gambiae may use other immune
mechanisms to recognise and fight viral infections. Our data
suggest that these mechanisms involve the complement-like
branch of the humoral immune response, and that the
melanisation response that is prominent in anti-parasitic immunity
is suppressed. The antiviral immune response in A. gambiae is thus
composed of some key conserved mechanisms to target viral
infection such as RNAi but includes other diverse and possibly
species-specific mechanisms.
Supporting Information
Figure S1 Qrt-PCR confirmation of virally responsive
genes. The expression of 3 virally responsive genes ascertained by
microarray analysis (white diamonds) was confirmed using qrt-
PCR (black diamonds). cDNA was generated from RNA extracted
from 59ONNVic-eGFP infected and mock infected (LacZ control)
mosquitoes. Transcript levels are expressed as the fold change of
those observed in the LacZ control. Error bars represent standard
deviation of 3 biological replicates.
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eGFP infection. Two-fold or greater fold change ratios are
shown in black text for 1DPI, 4DPI and 9DPI. Fold change ratios
less than 2-fold regulated that have passed all filters outlines in the
materials and methods excluding filtering on fold change ratio, are
shown in grey text. Putative functions/functional domains were
derived from Gene ontology terms, Interpro domains and
functions of orthologous genes (www.vectorbase.org).
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Table S2 Immune genes regulated by viral infection at
days 1,4 and 9 post infection. Two-fold or greater fold change
ratios are shown in black text for 1DPI, 4DPI and 9DPI).. Fold
change ratios less than 2-fold regulated that have passed all filters
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to their 59 ends, ensuring no overlap between sections used for
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